What type of study is this?

This is a Systematic Review study.

What question did this study set out to answer?

This review aims to synthesize genetic and clinical data on severe hypertriglyceridemia and its implications for treatment.

November 11, 2025GenesOpen Access

View Full Paper

Ask AI

Bookmark

Authors

Systematic review reveals genetic factors and metabolic dysfunction in severe hypertriglyceridemia, suggesting targeted therapies.

This review aims to synthesize genetic and clinical data on severe hypertriglyceridemia and its implications for treatment.
Systematic review of literature up to 2025
Data extracted on genetic variants and metabolic features
Analysis of therapeutic outcomes in adults with triglyceride levels ≥ 500 mg/dL.
Biallelic variants account for <5% of severe hypertriglyceridemia cases with high pancreatitis prevalence
Polygenic hypertriglyceridemia represents 70–80% of cases with intermediate triglyceride levels
Interventional therapies demonstrated significant triglyceride reductions with APOC3 and ANGPTL3 targeting.

Luca et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark